At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 840 enrolled
Drug / intervention
Bromfenac Ophthalmic Solution A +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
In Brief
A Phase 3 clinical trial evaluating Bromfenac Ophthalmic Solution A, Bromfenac Ophthalmic Solution B, and 1 other intervention for Dry Eye Syndrome. Completed, enrolled 840 participants across 1 site.
Detailed Summary
A dose ranging study to evaluate safety and efficacy of bromfenac ophthalmic solution in dry eye disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndrome
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2010
First PostedSep 2010
Primary CompletionAug 2011
Study CompletionDec 2011
TodayJul 2026
First PostedSep 30, 2010
Enrollment StartSep 1, 2010
Primary CompletionAug 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.8 years ago
Interventions
Bromfenac Ophthalmic Solution Adrug
sterile ophthalmic solution
Bromfenac Ophthalmic Solution Bdrug
sterile ophthalmic solution
Placebo Comparatordrug
sterile ophthalmic solution